{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:45:20Z","timestamp":1789764320606,"version":"4.0.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100022554","name":"Institut du Cerveau et de la Moelle Epini\u00e8re","doi-asserted-by":"publisher","award":["CM143"],"award-info":[{"award-number":["CM143"]}],"id":[{"id":"10.13039\/501100022554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022554","name":"Institut du Cerveau et de la Moelle Epini\u00e8re","doi-asserted-by":"publisher","award":["ANR-10- IAIHU-06"],"award-info":[{"award-number":["ANR-10- IAIHU-06"]}],"id":[{"id":"10.13039\/501100022554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jconrel.2025.114307","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:36:33Z","timestamp":1760196993000},"page":"114307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["Encapsulated cells as an enzyme replacement therapy for metachromatic leukodystrophy"],"prefix":"10.1016","volume":"388","author":[{"given":"Emilie","family":"Audouard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florine","family":"Chereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Lupiet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Mansat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Roger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Libert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena-Gaia","family":"Banchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Khefif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Farabos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonin","family":"Lamaziere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Anne","family":"Colle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Folcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Sevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Piguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114307_bb0005","series-title":"Scriver\u2019s Online Metabolic and Molecular Bases of Inherited Disease","article-title":"Metachromatic Leukodystrophy","author":"Gieselmann","year":"2006"},{"key":"10.1016\/j.jconrel.2025.114307_bb0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10545-007-0540-z","article-title":"Enzyme, cell and gene-based therapies for metachromatic leukodystrophy","volume":"30","author":"Sevin","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.jconrel.2025.114307_bb0015","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s10545-011-9361-1","article-title":"Metachromatic leukodystrophy: natural course of cerebral MRI changes in relation to clinical course","volume":"34","author":"Groeschel","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.jconrel.2025.114307_bb0020","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.beem.2014.10.001","article-title":"Metachromatic leukodystrophy: disease spectrum and approaches for treatment","volume":"29","author":"Van Rappard","year":"2015","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jconrel.2025.114307_bb0025","first-page":"692","article-title":"Metachromatic Leukodystrophy: diagnosis, modeling, and treatment approaches","volume":"7","author":"Shaimardanova","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.jconrel.2025.114307_bb0030","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(16)30374-9","article-title":"Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1\/2 trial","volume":"388","author":"Sessa","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2025.114307_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)02017-1","article-title":"Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1\/2 trial and expanded access","volume":"399","author":"Fumagalli","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2025.114307_bb0040","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science (1979)"},{"key":"10.1016\/j.jconrel.2025.114307_bb0045","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bbamcr.2008.08.009","article-title":"Treating lysosomal storage disorders: current practice and future prospects","volume":"1793","author":"Platt","year":"2009","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.jconrel.2025.114307_bb0050","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ymgme.2020.07.002","article-title":"Safety of intrathecal delivery of recombinant human arylsulfatase a in children with metachromatic leukodystrophy: results from a phase 1\/2 clinical trial","volume":"131","author":"\u00ed Dali","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jconrel.2025.114307_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107744","article-title":"A phase 2 study assessing TAK-611150\u00a0mg intrathecal weekly in patients with late-infantile metachromatic leukodystrophy (SHP611\u2013201; EMBOLDEN) compared to matched historical control data from children with late-infantile MLD (GLIA-MLD)","volume":"141","author":"Adang","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jconrel.2025.114307_bb0060","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1111\/j.1582-4934.2008.00322.x","article-title":"Treatment of diabetic rats with encapsulated islets","volume":"12","author":"Sweet","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jconrel.2025.114307_bb0065","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.biomaterials.2013.09.071","article-title":"A high-capacity cell macroencapsulation system supporting the long-term survival of genetically engineered allogeneic cells","volume":"35","author":"Lathuili\u00e8re","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114307_bb0070","doi-asserted-by":"crossref","first-page":"10578","DOI":"10.3390\/ijms160510578","article-title":"Encapsulated cellular implants for recombinant protein delivery and therapeutic modulation of the immune system","volume":"16","author":"Lathuili\u00e8re","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.114307_bb0075","series-title":"Cell Encapsulation: Overcoming Barriers in Cell Transplantation in Diabetes and Beyond","author":"Farina","year":"2018"},{"key":"10.1016\/j.jconrel.2025.114307_bb0080","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1073\/pnas.1018987108","article-title":"Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration","volume":"108","author":"Zhang","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2025.114307_bb0085","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ajo.2013.03.021","article-title":"Randomized trial of ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for retinitis Pigmentosa","volume":"156","author":"Birch","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2025.114307_bb0090","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajo.2016.07.013","article-title":"Long-term follow-up of patients with retinitis Pigmentosa receiving intraocular ciliary neurotrophic factor implants","volume":"170","author":"Birch","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2025.114307_bb0095","doi-asserted-by":"crossref","first-page":"7484","DOI":"10.1167\/iovs.12-9970","article-title":"Two-year intraocular delivery of ciliary neurotrophic factor by encapsulated cell technology implants in patients with chronic retinal degenerative diseases","volume":"53","author":"Kauper","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2025.114307_bb0100","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1089\/ten.2004.10.1617","article-title":"Sustained secretion of ciliary neurotrophic factor to the vitreous, using the encapsulated cell therapy-based NT-501 intraocular device","volume":"10","author":"Thanos","year":"2004","journal-title":"Tissue Eng."},{"key":"10.1016\/j.jconrel.2025.114307_bb0105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000336051","article-title":"Encapsulated cell biodelivery of nerve growth factor to the basal forebrain in patients with Alzheimer\u2019s disease","volume":"33","author":"Eriksdotter-J\u00f6nhagen","year":"2012","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.jconrel.2025.114307_bb0110","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3233\/JAD-141068","article-title":"Brain changes in Alzheimer\u2019s disease patients with implanted encapsulated cells releasing nerve growth factor","volume":"43","author":"Ferreira","year":"2014","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.jconrel.2025.114307_bb0115","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3233\/JAD-141068","article-title":"Brain changes in Alzheimer\u2019s disease patients with implanted encapsulated cells releasing nerve growth factor","volume":"43","author":"Ferreira","year":"2015","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.jconrel.2025.114307_bb0120","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1051\/medsci\/20173301013","article-title":"Un implant bioactif pour pr\u00e9venir la maladie d\u2019Alzheimer","volume":"33","author":"Lathuili\u00e8re","year":"2017","journal-title":"m\u00e9decine\/sciences"},{"key":"10.1016\/j.jconrel.2025.114307_bb0125","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1093\/brain\/aww036","article-title":"A subcutaneous cellular implant for passive immunization against amyloid-\u03b2 reduces brain amyloid and tau pathologies","volume":"139","author":"Lathuili\u00e8re","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.jconrel.2025.114307_bb0130","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1089\/hum.2004.15.968","article-title":"Neuroprotective gene therapy for Huntington\u2019s disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study","volume":"15","author":"Bloch","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2025.114307_bb0135","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1089\/10430340050111377","article-title":"Neuroprotective gene therapy for Huntington\u2019s disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF","volume":"11","author":"Bachoud-L\u00e9vi","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2025.114307_bb0140","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3171\/jns.2003.98.4.0874","article-title":"Stereotactic transplantation of a dopamine-producing capsule into the striatum for treatment of Parkinson disease: a preclinical primate study","volume":"98","author":"Yoshida","year":"2003","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.jconrel.2025.114307_bb0145","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.expneurol.2007.08.019","article-title":"Encapsulated cell biodelivery of GDNF: a novel clinical strategy for neuroprotection and neuroregeneration in Parkinson\u2019s disease?","volume":"209","author":"Lindvall","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jconrel.2025.114307_bb0150","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nm0696-696","article-title":"Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients","volume":"2","author":"Aebischer","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.114307_bb0155","doi-asserted-by":"crossref","first-page":"9738","DOI":"10.1021\/acsnano.7b01008","article-title":"Heart repair using Nanogel-encapsulated human cardiac stem cells in mice and pigs with myocardial infarction","volume":"11","author":"Tang","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114307_bb0160","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000341649","article-title":"Cell-based strategies for the treatment of kidney dysfunction: a review","volume":"34","author":"Pino","year":"2012","journal-title":"Blood Purif."},{"key":"10.1016\/j.jconrel.2025.114307_bb0165","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1126\/science.aau7187","article-title":"Electrogenetic cellular insulin release for real-time glycemic control in type 1 diabetic mice","volume":"368","author":"Krawczyk","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.114307_bb0170","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.drudis.2020.11.019","article-title":"Cell microencapsulation technologies for sustained drug delivery: clinical trials and companies","volume":"26","author":"Lopez-Mendez","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2025.114307_bb0175","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1517\/14712598.6.7.717","article-title":"Application of encapsulated cell technology for retinal degenerative diseases","volume":"6","author":"Tao","year":"2006","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.jconrel.2025.114307_bb0180","doi-asserted-by":"crossref","DOI":"10.2337\/db18-138-OR","article-title":"Initial clinical evaluation of VC-01TM combination product\u2014a stem cell\u2013derived islet replacement for type 1 diabetes (T1D)","volume":"67","author":"Henry","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.jconrel.2025.114307_bb0185","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/nbt.3033","article-title":"Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells","volume":"32","author":"Rezania","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114307_bb0190","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/cgt.2011.22","article-title":"Cell encapsulation technology as a novel strategy for human anti-tumor immunotherapy","volume":"18","author":"Schwenter","year":"2011","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jconrel.2025.114307_bb0195","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1523\/JNEUROSCI.4785-13.2014","article-title":"Comparison of five peptide vectors for improved brain delivery of the lysosomal enzyme arylsulfatase a","volume":"34","author":"B\u00f6ckenhoff","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2025.114307_bb0200","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2119\/2007-00063.Matzner","article-title":"Induction of tolerance to human arylsulfatase a in a mouse model of metachromatic leukodystrophy","volume":"13","author":"Matzner","year":"2007","journal-title":"Mol. Med."},{"key":"10.1016\/j.jconrel.2025.114307_bb0205","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1089\/hum.2007.048","article-title":"Safety of arylsulfatase a overexpression for gene therapy of metachromatic leukodystrophy","volume":"18","author":"Capotondo","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2025.114307_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.620967","article-title":"Optimized protocol for subcutaneous implantation of encapsulated cells device and evaluation of biocompatibility","volume":"9","author":"Audouard","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114307_bb0215","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/hmg\/ddi425","article-title":"Intracerebral adeno-associated virus-mediated gene transfer in rapidly progressive forms of metachromatic leukodystrophy","volume":"15","author":"Sevin","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jconrel.2025.114307_bb0220","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1089\/hum.2012.015","article-title":"Correction of brain oligodendrocytes by AAVrh.10 intracerebral gene therapy in metachromatic leukodystrophy mice","volume":"23","author":"Piguet","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2025.114307_bb0225","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1212\/WNL.20.1.52","article-title":"A pedigree studv of metachromatic leukodystrophy: biochemical identification of the carrier state","volume":"20","author":"Bass","year":"1970","journal-title":"Neurology"},{"key":"10.1016\/j.jconrel.2025.114307_bb0230","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/sj.gt.3301232","article-title":"Long-term expression and transfer of arylsulfatase a into brain of arylsulfatase A-deficient mice transplanted with bone marrow expressing the arylsulfatase a cDNA from a retroviral vector","volume":"7","author":"Matzner","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2025.114307_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.677895","article-title":"Complete correction of brain and spinal cord pathology in metachromatic leukodystrophy mice","volume":"14","author":"Audouard","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jconrel.2025.114307_bb0240","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jconrel.2022.11.008","article-title":"Bioelectronic cell-based device provides a strategy for the treatment of the experimental model of multiple sclerosis","volume":"352","author":"Audouard","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114307_bb0245","doi-asserted-by":"crossref","first-page":"14821","DOI":"10.1073\/pnas.93.25.14821","article-title":"Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy","volume":"93","author":"Hess","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114307_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101248","article-title":"Dose-response evaluation of intravenous gene therapy in a symptomatic mouse model of metachromatic leukodystrophy","volume":"32","author":"Audouard","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jconrel.2025.114307_bb0255","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/088307389901400402","article-title":"Slow progression of juvenile metachromatic leukodystrophy 6 years after bone marrow transplantation","volume":"14","author":"Kapaun","year":"1999","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.jconrel.2025.114307_bb0260","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/archneur.1992.00530280095028","article-title":"Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis","volume":"49","author":"Hyde","year":"1992","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jconrel.2025.114307_bb0265","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/acn3.51254","article-title":"Intravenous arylsulfatase a in metachromatic leukodystrophy: a phase 1\/2 study","volume":"8","author":"Dali","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jconrel.2025.114307_bb0270","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/mt.2015.145","article-title":"Long-term improvements in lifespan and pathology in CNS and PNS after BMT plus one intravenous injection of AAVrh10-GALC in Twitcher mice","volume":"23","author":"Rafi","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114307_bb0275","series-title":"Islet Encapsulation: New Developments for the Treatment of Type 1 Diabetes","volume":"1","author":"Zhang","year":"2022"},{"key":"10.1016\/j.jconrel.2025.114307_bb0280","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/978-1-0716-0215-7_32","article-title":"Clinical applications of cell encapsulation technology","volume":"2100","author":"Santos-Vizcaino","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2025.114307_bb0285","article-title":"Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer\u2019s disease patients: application of a second-generation encapsulated cell biodelivery device","volume":"8","author":"Eyjolfsdottir","year":"2016","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"10.1016\/j.jconrel.2025.114307_bb0290","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00401-016-1547-z","article-title":"The role of APOE in cerebrovascular dysfunction","volume":"131","author":"Tai","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jconrel.2025.114307_bb0295","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/mt.2008.305","article-title":"Enzyme replacement improves ataxic gait and central nervous system histopathology in a mouse model of metachromatic leukodystrophy","volume":"17","author":"Matzner","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114307_bb0300","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddz020","article-title":"Evolutionary redesign of the lysosomal enzyme arylsulfatase a increases efficacy of enzyme replacement therapy for metachromatic leukodystrophy","author":"Simonis","year":"2019","journal-title":"Hum. Mol. Genet."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925009204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925009204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:47:09Z","timestamp":1777510029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925009204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":60,"alternative-id":["S0168365925009204"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114307","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Encapsulated cells as an enzyme replacement therapy for metachromatic leukodystrophy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114307","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114307"}}